Karen Prange Insider Trading $NVRO NEVRO CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Karen Prange.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Karen Prange. Karen Prange is SVP&Pres, Uro & Pelvic Health in BOSTON SCIENTIFIC CORP ($BSX) and SVP&Pres, Uro & Women's Health in BOSTON SCIENTIFIC CORP ($BSX) and Director in CANTEL MEDICAL CORP ($CMN) and EVP&CEO Gl.AH.Med.Den.Sur.Grp in HENRY SCHEIN INC ($HSIC) and Director in AtriCure, Inc. ($ATRC) and Director in NEVRO CORP ($NVRO).

Karen Prange in NEVRO CORP

Trading Symbol: NVRO
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Karen Prange: Director
Holdings: 2,703 shares
Current Value: $252,271
Latest Transaction: Dec 18 2019
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Karen Prange in NEVRO CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ATRC, BSX, CMN, HSIC, NVRO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 18 2019NVRONEVRO CORPPrange KarenDirectorGrantA0.002,70302,7030 to 2.7 K

Page:   1